Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28612485
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28612485
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Cancer+Med
2017 ; 6
(7
): 1523-1530
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Renal impairment and use of nephrotoxic agents in patients with multiple myeloma
in the clinical practice setting in the United States
#MMPMID28612485
Qian Y
; Bhowmik D
; Bond C
; Wang S
; Colman S
; Hernandez RK
; Cheng P
; Intorcia M
Cancer Med
2017[Jul]; 6
(7
): 1523-1530
PMID28612485
show ga
Renal impairment is a common complication of multiple myeloma and deterioration
in renal function or renal failure may complicate clinical management. This
retrospective study in patients with multiple myeloma using an electronic medical
records database was designed to estimate the prevalence of renal impairment
(single occurrence of estimated glomerular filtration rate [eGFR] <60 mL/min per
1.73 m(2) on or after multiple myeloma diagnosis) and chronic kidney disease (at
least two eGFR values <60 mL/min per 1.73 m(2) after multiple myeloma diagnosis
that had been measured at least 90 days apart), and to describe the use of
nephrotoxic agents. Eligible patients had a first diagnosis of multiple myeloma
(ICD-9CM: 203.0x) between January 1, 2012 and March 31, 2015 with no prior
diagnoses in the previous 6 months. Of 12,370 eligible patients, the prevalence
of both renal impairment and chronic kidney disease during the follow-up period
was high (61% and 50%, respectively), and developed rapidly following the
diagnosis of multiple myeloma (6-month prevalence of 47% and 27%, respectively).
Eighty percent of patients with renal impairment developed chronic kidney disease
over the follow-up period, demonstrating a continuing course of declining kidney
function after multiple myeloma diagnosis. Approximately 40% of patients with
renal impairment or chronic kidney disease received nephrotoxic agents, the
majority of which were bisphosphonates. As renal dysfunction may impact the
clinical management of multiple myeloma and is associated with poor prognosis,
the preservation of renal function is critical, warranting non-nephrotoxic
alternatives where possible in managing this population.
|*Practice Patterns, Physicians'
[MESH]
|Antineoplastic Agents/*adverse effects/therapeutic use
[MESH]
|Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use
[MESH]